Windjammer Capital-backed Hilco Vision added-on Bruder Healthcare, which provides therapeutic and ophthalmic products to medical professionals and consumers. Bruder is the fourth add-on to Hilco since Windjammer acquired the company in September 2019.
Windjammer Capital Investors is pleased to announce that its portfolio company, Hilco Vision (“Hilco”) has acquired Bruder Healthcare (“Bruder”) effective September 17, 2021. The terms of the transaction were not disclosed.
Bruder Healthcare (https://bruder.com) has delivered therapeutic and ophthalmic products to medical professionals and consumers for more than 35 years. With its patented technologies, Bruder has become a leading provider of relief for the millions of people who suffer from dry eye and other ocular surface conditions. Bruder’s core products include eye compresses and lid hygiene cleansers, which provide eye care professionals a range of solutions to address these conditions. The Company’s products are broadly available under the Bruder® and Thermalon® brands.
The business will continue to be based out of Alpharetta, GA.
Ross Brownlee, CEO of Hilco Vision noted, “We have been fortunate to be a distribution partner of Bruder Healthcare for many years and know firsthand the quality and impact their product range has on those dealing with dry eye or ocular surface conditions. Bruder’s leading reputation with doctors and patients alike is well earned. We look to build on their existing partnerships and expand that reach even more broadly.”
“We have been dedicated to bringing eyecare solutions to doctors and their patients for over 35 years and our brand is synonymous with any treatment regimen for addressing ocular surface conditions. We felt Hilco Vision was an ideal partner to ensure the continued growth of our brands in North America and globally,” stated Mark Bruder, CEO of Bruder Healthcare.
Bruder marks Hilco’s fourth add-on investment since Windjammer Capital acquired the company in September 2019.
“We are excited to work with and support Hilco’s ongoing efforts to provide the most comprehensive product solutions to its professional eyecare customers,” said Matt Anderson, Managing Director at Windjammer Capital. “Hilco offers a compelling value proposition through both its organic and acquisition-oriented activities, and we will continue to seek add-on opportunities that enhance its product portfolio and deliver best in class service to the eyecare market.”
For more information on HSG please visit its website at www.hilcovision.com.
Please contact Greg Bondick (firstname.lastname@example.org) or Matt Anderson (email@example.com) at Windjammer with any questions regarding the transaction.
About Windjammer Capital
Windjammer Capital is a national private equity investment firm, based in Newport Beach, CA and Waltham, MA that invests control equity in middle-market businesses and in partnership with management. Since its founding in 1990, Windjammer has managed over $2 billion of committed capital with respect to its control equity investment strategy, and since inception has completed over 60 platform investments and more than 160 strategic add-ons. The firm targets investments in companies that are leaders in attractive niche markets and share several of the following characteristics: significant and defensible market positions; differentiated products and services; strong management teams; scalable business models; identifiable growth opportunities; and consistent financial performance. www.windjammercapital.com
About Hilco Vision
Hilco Vision is an industry leading global vision care company delivering comprehensive solutions to customers, built on a platform of innovation and operational excellence. It has direct subsidiaries in the USA, Canada, UK, Germany, Australia, China, and the Netherlands. The company’s product portfolio is concentrated on 5 primary product categories: Professional Optical Tools, Ophthalmic Supplies, Vision Protection, Consumer Accessories and Lenscare.